Friday 6 November 2026 Export PEN’s income statement to Excel — free account

Penumbra, Inc.

PEN Healthcare Medical Devices

Penumbra, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.5% from fiscal 2024.

Revenue: +15.6%
EPS: −8.29%
Free cash flow: −37.2%
Total debt: −10.3%

Quarter to September 2026, against a year earlier

319.20 1.91 −0.59%

Follow PEN

Alert me

Market cap: $12.7B
P/E: 80.3×
Fwd P/E: 68.7×
Dividend yield: —
F-score: 8/9
Altman Z: 20.17
Beneish M: −2.48
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Penumbra, Inc. 10-Q filed May 6, 2026

Fiscal Q1 2026 · Period ended Mar 31, 2026 · Filed May 6, 2026 · accepted 4:45 PM ET · Document on sec.gov · Filing index

Nothing in this filing raised a red flag. The document itself is on sec.gov.

Read the filing on sec.gov